Newsletter | 01 September 2003 Access News 9, Focus on South Africa, September 2003 INTELLECTUAL PROPERTY AND TRADE This editions focus is on South Africa and the changing times, understanding patents, the Free Trade Area of the Americas, the ups and downs of the pharma industry and the G8s betrayal of people in developing countries. Read, watch, share Filter by - Any -BlogEventsFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePress releaseReportResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Letter Letter | 01 November 2023 Intellectual property and trade Letter: Civil society calls on UK Prime Minister to ensure UK-India free trade agreement does not threaten access to affordable medicines Photo credit: Pablo Garrigos/MSF Press release Press release | 04 October 2023 HIV/AIDS Intellectual property and trade In step to expand people's access to HIV treatment, Colombia plans to overcome patent barriers and issue a compulsory license 5 min Letter | 21 September 2023 Intellectual property and trade Ukraine Ukraine: Open Letter: Urgent action by Johnson & Johnson needed to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis Letter | 21 September 2023 Intellectual property and trade Republic of Moldova Moldova: Open Letter: CSOs request urgent action by Johnson & Johnson to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis Technical brief | 15 September 2023 Pandemic preparedness Intellectual property and trade From TRIPS to PPR: Addressing Intellectual Property Barriers on Lifesaving Medical Products Technical brief | 17 July 2023 Pandemic preparedness Intellectual property and trade Research and development MSF Position Paper: Ensuring Timely and Equitable Access to Medical Products in Global Public Health Emergencies Photo credit: Prem Hessenkamp Press release Press release | 13 July 2023 Intellectual property and trade Tuberculosis TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries 2 min Photo credit: Marta Soszynska/MSF Press release Press release | 13 July 2023 HIV/AIDS Intellectual property and trade Colombia Colombia to challenge AIDS drug patents 3 min Load More
Letter Letter | 01 November 2023 Intellectual property and trade Letter: Civil society calls on UK Prime Minister to ensure UK-India free trade agreement does not threaten access to affordable medicines
Photo credit: Pablo Garrigos/MSF Press release Press release | 04 October 2023 HIV/AIDS Intellectual property and trade In step to expand people's access to HIV treatment, Colombia plans to overcome patent barriers and issue a compulsory license 5 min
Letter | 21 September 2023 Intellectual property and trade Ukraine Ukraine: Open Letter: Urgent action by Johnson & Johnson needed to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis
Letter | 21 September 2023 Intellectual property and trade Republic of Moldova Moldova: Open Letter: CSOs request urgent action by Johnson & Johnson to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis
Technical brief | 15 September 2023 Pandemic preparedness Intellectual property and trade From TRIPS to PPR: Addressing Intellectual Property Barriers on Lifesaving Medical Products
Technical brief | 17 July 2023 Pandemic preparedness Intellectual property and trade Research and development MSF Position Paper: Ensuring Timely and Equitable Access to Medical Products in Global Public Health Emergencies
Photo credit: Prem Hessenkamp Press release Press release | 13 July 2023 Intellectual property and trade Tuberculosis TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries 2 min
Photo credit: Marta Soszynska/MSF Press release Press release | 13 July 2023 HIV/AIDS Intellectual property and trade Colombia Colombia to challenge AIDS drug patents 3 min
